Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol Effects on Median Effective Dose of Esketamine in Children Undergoing Ambulatory Circumcision
ChiCTR2200061480Phase 4Recruiting
- Sponsor
- Shanghai Children's Medical Center
- Start
- Jun 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esmolol and esketamine in hypertension (HTN), tachyarrhythmia and procedural pain (2 arms), sponsored by Shanghai Children's Medical Center. Primary endpoint: Body movement during skin incision. Started Jun 2022; status: recruiting.
02
Drugs
esmololesketamine
03
Conditions
hypertension (HTN)tachyarrhythmiaprocedural pain
Beyond the preview
Go deeper on ChiCTR2200061480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061480.